Notch在甲状腺C细胞发育及甲状腺髓样癌治疗中的作用
Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.
作者信息
Cook Mackenzie, Yu Xiao-Min, Chen Herbert
机构信息
Section of Endocrine Surgery, Department of Surgery, University of Wisconsin Madison, Wisconsin.
出版信息
Am J Transl Res. 2010 Feb 10;2(1):119-25.
Abstract
The Notch pathway plays an important role in the normal development of neuroendocrine cells, including the calcitonin producing C-cells of the thyroid. This effect has been elucidated to be mediated through modulation of Achaete-Scute Complex Like 1 (ASCL1), a transcription factor associated with poor prognosis in neuroendocrine cancer. Medullary thyroid cancer (MTC) is one of the neuroendocrine cancers derived from the thyroid C-cells. The Notch pathway has been shown to be inactive in MTC which may lead to altered expression of ASCL1. Artificial induction of Notch signaling in MTC cells can suppress ASCL1 expression, the cell growth as well as hormone secreting potential. Pharmacological activation of the Notch pathway also successfully suppresses the tumor growth in an animal model, which sheds light on the targeted therapy of Notch as a potential treatment for intractable MTC.
摘要
Notch信号通路在神经内分泌细胞的正常发育中起重要作用，包括甲状腺产生降钙素的C细胞。已阐明这种作用是通过调节类Achaete-Scute复合体1（ASCL1）介导的，ASCL1是一种与神经内分泌癌预后不良相关的转录因子。甲状腺髓样癌（MTC）是源自甲状腺C细胞的神经内分泌癌之一。已证明Notch信号通路在MTC中无活性，这可能导致ASCL1表达改变。在MTC细胞中人工诱导Notch信号可抑制ASCL1表达、细胞生长以及激素分泌潜能。Notch信号通路的药理学激活在动物模型中也成功抑制了肿瘤生长，这为将Notch作为难治性MTC的潜在治疗方法进行靶向治疗提供了思路。
相似文献
1
Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.
Am J Transl Res. 2010 Feb 10;2(1):119-25.
2
Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
J Biol Chem. 2006 Dec 29;281(52):39819-30. doi: 10.1074/jbc.M603578200. Epub 2006 Nov 7.
3
Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer.
Am J Surg. 2010 Mar;199(3):315-8; discussion 318. doi: 10.1016/j.amjsurg.2009.08.034.
4
Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
Hum Cell. 2017 Jan;30(1):1-10. doi: 10.1007/s13577-016-0149-3. Epub 2016 Oct 26.
5
Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
Oncologist. 2008 Feb;13(2):98-104. doi: 10.1634/theoncologist.2007-0190.
6
Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Oncogene. 2005 Oct 27;24(47):7073-83. doi: 10.1038/sj.onc.1208865.
7
Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.
Cancer Med. 2013 Oct;2(5):734-43. doi: 10.1002/cam4.118. Epub 2013 Sep 17.
8
The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
Surgery. 2003 Dec;134(6):866-71; discussion 871-3. doi: 10.1016/s0039-6060(03)00418-5.
9
Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1.
Surgery. 1996 Aug;120(2):168-72; discussion 173. doi: 10.1016/s0039-6060(96)80284-4.
10
Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1.
Thyroid. 2005 Jun;15(6):511-21. doi: 10.1089/thy.2005.15.511.
引用本文的文献
1
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.
Signal Transduct Target Ther. 2024 May 27;9(1):128. doi: 10.1038/s41392-024-01828-x.
2
DLL3 (delta-like protein 3) expression correlates with stromal desmoplasia and lymph node metastases in medullary thyroid carcinomas.
Endocr Connect. 2021 Mar;10(3):283-289. doi: 10.1530/EC-20-0611.
3
Notch Signaling in Thyroid Cancer.
Adv Exp Med Biol. 2021;1287:155-168. doi: 10.1007/978-3-030-55031-8_10.
4
Notch3 as a novel therapeutic target in metastatic medullary thyroid cancer.
Surgery. 2018 Jan;163(1):104-111. doi: 10.1016/j.surg.2017.07.039. Epub 2017 Nov 8.
5
Targeted Therapy for Medullary Thyroid Cancer: A Review.
Front Oncol. 2017 Oct 6;7:238. doi: 10.3389/fonc.2017.00238. eCollection 2017.
6
MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
Mol Cancer. 2017 Jan 26;16(1):24. doi: 10.1186/s12943-016-0563-x.
7
Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells.
Cancer Res. 2016 Feb 1;76(3):582-93. doi: 10.1158/0008-5472.CAN-15-1199. Epub 2015 Nov 25.
8
Induction of apoptosis and autophagy in metastatic thyroid cancer cells by valproic acid (VPA).
Int J Clin Exp Pathol. 2015 Jul 1;8(7):8291-7. eCollection 2015.
9
Identification of novel thyroid cancer-related genes and chemicals using shortest path algorithm.
Biomed Res Int. 2015;2015:964795. doi: 10.1155/2015/964795. Epub 2015 Mar 22.
10
Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction.
Mol Cancer Ther. 2015 Feb;14(2):499-512. doi: 10.1158/1535-7163.MCT-14-0073. Epub 2014 Dec 15.
本文引用的文献
1
Notch signaling: the core pathway and its posttranslational regulation.
Dev Cell. 2009 May;16(5):633-47. doi: 10.1016/j.devcel.2009.03.010.
2
Multi-targeted approach in the treatment of thyroid cancer.
Ther Clin Risk Manag. 2008 Oct;4(5):935-47. doi: 10.2147/tcrm.s3062.
3
Carcinoid tumors.
Oncologist. 2008 Dec;13(12):1255-69. doi: 10.1634/theoncologist.2008-0207. Epub 2008 Dec 17.
4
Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
Ann Surg Oncol. 2008 Sep;15(9):2600-5. doi: 10.1245/s10434-008-0006-z. Epub 2008 Jun 18.
5
Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
Ann Surg. 2008 Jun;247(6):1036-40. doi: 10.1097/SLA.0b013e3181758d0e.
6
Current management of medullary thyroid cancer.
Oncologist. 2008 May;13(5):539-47. doi: 10.1634/theoncologist.2007-0239.
7
Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
Oncologist. 2008 Feb;13(2):98-104. doi: 10.1634/theoncologist.2007-0190.
8
Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.
J Gastrointest Surg. 2007 Nov;11(11):1515-20; discussion 1520. doi: 10.1007/s11605-007-0249-1. Epub 2007 Sep 15.
9
Palliation of advanced thyroid malignancies.
Surg Oncol. 2007 Dec;16(4):237-47. doi: 10.1016/j.suronc.2007.08.006. Epub 2007 Sep 14.
10
Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
Oncologist. 2007 Aug;12(8):942-51. doi: 10.1634/theoncologist.12-8-942.
Zotero 插件